BIOC(Delisted)
BioceptยทNASDAQ
--
--(--)
BIOC Profile
Biocept, Inc.
A leading provider of molecular diagnostic assays, products and services
9955 Mesa Rim Road
, San Diego
, California 92121
--
Biocept, Inc., was founded in California on May 12, 1997. It is a commercial cancer diagnostic company. Research and work on the detection of circulating tumor cells and cancer cells, using a standard blood sample to improve treatment effectiveness, and enabling oncologists to provide patients with more detailed and better information about their cancer cells. The company established the Laboratory, which was accredited by the Clinical Trials Act, passed in 1988, and the American College of Pathology. It produces in-substrate etching microfluidic channels, related equipment and reagents, and then tests them with one of their devices in San Diego. Accreditation and accreditation under the Clinical Experiments Act is a precondition for conducting any human testing in terms of access to diagnostic information, prevention, and disease treatment, or health. The tests they provide are called laboratory-developed diagnostic reagents and comply with the provisions of the Clinical Experiments Act.
